ABSTRACT
Extracts from natural product sources have served as a valuable source of molecular diversity in many drug discovery programs, and several important drugs have been isolated from natural products. In any natural product isolation program in which the endproduct is to be a drug or a lead compound, some type of bioassay screening or pharmacological evaluation must necessarily be used to guide the isolation process towards the pure bioactive component.
